Zacks Research Has Positive Outlook of BAX FY2026 Earnings

Baxter International Inc. (NYSE:BAX) – Stock analysts at Zacks Research increased their FY2026 earnings estimates for Baxter International in a research report issued to clients and investors on Thursday, August 20th. Zacks Research analyst Team now anticipates that the medical instruments supplier will post earnings per share of $2.02 for the year, up from their previous estimate of $1.83. Zacks Research currently has a “Hold” rating on the stock. The consensus estimate for Baxter International’s current full-year earnings is $2.04 per share. Zacks Research also issued estimates for Baxter International’s FY2027 earnings at $2.00 EPS.

Baxter International (NYSE:BAX) last issued its quarterly earnings results on Thursday, July 30th. The medical instruments supplier reported $0.56 EPS for the quarter, topping analysts’ consensus estimates of $0.37 by $0.19. The company had revenue of $2.96 billion for the quarter, compared to analyst estimates of $2.80 billion. Baxter International had a negative net margin of 9.27% and a positive return on equity of 16.57%. Baxter International’s revenue was up 5.3% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.59 earnings per share. Baxter International has set its FY 2026 guidance at 1.950-2.150 EPS.

Other equities research analysts have also recently issued research reports about the company. UBS Group increased their price target on Baxter International from $19.00 to $25.00 and gave the company a “hold” rating in a research note on Tuesday, July 28th. Wall Street Zen raised Baxter International from a “hold” rating to a “buy” rating in a research note on Saturday, August 1st. Barclays upped their target price on Baxter International from $25.00 to $27.00 and gave the company an “overweight” rating in a report on Friday, May 1st. Weiss Ratings raised shares of Baxter International from a “sell (d-)” rating to a “sell (d)” rating in a research report on Friday, July 31st. Finally, Wells Fargo & Company raised their price target on shares of Baxter International from $19.00 to $23.00 and gave the stock an “equal weight” rating in a report on Friday, July 31st. Two equities research analysts have rated the stock with a Buy rating, nine have issued a Hold rating and two have issued a Sell rating to the company’s stock. According to data from MarketBeat, Baxter International currently has an average rating of “Hold” and a consensus target price of $22.45.

Baxter International Stock Up 0.6%

Shares of BAX opened at $26.50 on Monday. The company has a market capitalization of $13.70 billion, a PE ratio of -12.80, a PEG ratio of 3.99 and a beta of 0.59. Baxter International has a 12 month low of $15.73 and a 12 month high of $30.00. The stock’s 50-day moving average price is $23.74 and its two-hundred day moving average price is $20.41. The company has a current ratio of 1.95, a quick ratio of 1.32 and a debt-to-equity ratio of 1.39.

Baxter International Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Thursday, October 1st. Shareholders of record on Friday, August 28th will be issued a dividend of $0.01 per share. This represents a $0.04 dividend on an annualized basis and a yield of 0.2%. The ex-dividend date is Friday, August 28th. Baxter International’s dividend payout ratio (DPR) is presently -1.93%.

Institutional Investors Weigh In On Baxter International

Institutional investors and hedge funds have recently made changes to their positions in the business. BlackRock Inc. bought a new stake in Baxter International in the second quarter worth approximately $1,744,874,000. Pzena Investment Management LLC bought a new position in shares of Baxter International during the 2nd quarter worth approximately $1,392,098,000. California State Teachers Retirement System grew its position in shares of Baxter International by 2,009.1% during the 2nd quarter. California State Teachers Retirement System now owns 12,720,343 shares of the medical instruments supplier’s stock worth $271,198,000 after buying an additional 12,117,222 shares during the period. Equity Investment Corp acquired a new position in shares of Baxter International during the 2nd quarter valued at $146,815,000. Finally, Bank of America Corp DE bought a new position in Baxter International during the second quarter worth $132,993,000. Institutional investors own 90.19% of the company’s stock.

About Baxter International

Baxter International Inc is a global healthcare company that develops, manufactures and markets a broad portfolio of medical products, pharmaceutical therapies and biotechnology-based solutions. The company’s primary business activities are organized around renal care, medication delivery, acute therapies, pharmacy automation, surgical care and biotechnology. Baxter’s offerings are designed to support patient care in hospitals, dialysis centers, nursing homes and other healthcare facilities worldwide.

In the renal care segment, Baxter provides hemodialysis and peritoneal dialysis systems, water treatment equipment and related disposables, including dialyzers, bloodlines and catheters.